DehydraTECH-liraglutide and select DehydraTECH-CBD formulations were the top performing blood sugar groups KELOWNA, BC – Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the “Company” or “Lexaria”), a global innovator in drug delivery platforms… Read More
Companies will discover and develop novel targets for the potential treatment of neuropsychiatric conditions New discovery program builds upon nearly two decades of partnership between AbbVie and Gedeon Richter NORTH CHICAGO,… Read More
Series C led by Lightspeed Venture Partners and Ascenta Capital with participation from top-tier new investor syndicate and existing investors Funding will advance distinctive pipeline of targeted radiopharmaceuticals through clinical… Read More
Seven UBC Faculty of Medicine doctoral students have been named to the 2024/2025 cohort of the UBC Public Scholars Initiative (PSI) Program. Selected based on their outstanding potential for public impact, the Faculty… Read More
Unique centralized service helps increase the supply of lungs for transplant, addressing a critical unmet need SILVER SPRING, MD & JACKSONVILLE, FLA – United Therapeutics Corporation (Nasdaq: UTHR), a public… Read More
